Trademark search for:

SEMVIS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2013-11-13 — Application filed
2014-02-17 — Sn assigned for sect 66a subseq desig from ib
2014-02-24 — Application filed
2014-02-25 — Application filed
2014-02-28 — Assigned to examiner
2014-03-01 — Application filed
2014-03-07 — Approved for pub - principal register
2014-03-26 — Notice of publication
2014-04-15 — Published for opposition
2014-07-01 — Registered-principal register
2014-07-31 — Grant of protection created, to be sent to ib
2014-08-11 — Final disposition recorded
2014-08-11 — Final disposition recorded
2014-08-29 — Notification processed by ib
2015-07-03 — Change of owner received from ib
2016-11-17 — International registration renewed
2021-02-26 — Cancelled section 71
2021-02-26 — Final status recorded
2021-10-26 — Total invalidation of reg ext protection created
2025-02-13 — Generic madrid transaction sent to ib
2025-02-13 — Generic madrid transaction created
2025-02-13 — Invalidation reviewed - no action required by office
2025-04-04 — Further decision processed by ib
2025-05-27 — New representative at ib received

Owner Information

Novartis AG
CH

Glaxosmithkline Biologicals S.A.
BE

Novartis AG
CH

Correspondent

Baker & McKenzie Zurich
Holbeinstrasse 30
CH-8034 Zürich,
SWITZERLAND

Filing Details

Filing Date:
2013-11-13

Status Date:
2021-02-26

Category:
Pharmaceuticals

Filing Year:
2006

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.